Advancells wins award for excellence in regenerative medicine at Corporate LiveWire Awards

New Delhi [India], Dec. 24 : Further fostering its leadership stance in modern medicine, Noida-based stem cells therapy solution provider, Advancells, won recognition at the recently concluded Corporate LiveWire Healthcare and Life Sciences Awards 2016. [NK Health] The pioneer stem cell company was felicitated for its superior performance in regenerative medicine and for its consistent excellence in medical research.

Scientists develop new ultrasound technique to ‘see’ inside live cells

Researchers have developed a new technique that uses sound rather than light to see inside live cells, an advance that may have potential applications in stem-cell transplants and cancer diagnosis. The technique uses shorter-than-optical wavelengths of sound and could even rival the optical super-resolution techniques which won the 2014 Nobel Prize for Chemistry, researchers said.

Human embryo discovery wins Peoples Choice of Science Breakthrough of the Year

First molecular glimpse : The system developed by Rockefeller scientists that has given researchers the ability to study the molecular events that occur during early human development won the People’s Choice of Science magazine’s Breakthrough of the Year. A revolutionary method developed by Rockefeller University scientists that allows researchers to study human embryo development in the lab has been voted Breakthrough of the Year by Science magazine readers.

Kiadis Pharma provides update on second dose trial (CR-AIR-008) with ATIR101a

The Company will continue its CR-AIR-008 trial, treating patients with a single dose of ATIR101TM according to the recommendation of the Independent Data Monitoring Committee and according to the clinical protocol. In this ongoing exploratory Phase II trial the safety and efficacy of a second dose of ATIR101TM is being tested in patients to investigate product flexibility in administering a further dose of ATIR101TM should it be needed by physicians.

Replacing missing gut bacteria could help treat children with rare autoimmune disease

Defects in the body’s regulatory T cells cause inflammation and autoimmune disease by altering the type of bacteria living in the gut, researchers from The University of Texas Health Science Center at Houston have discovered. The study, “Resetting microbiota by Lactobacillus reuteri inhibits T reg deficiency-induced autoimmunity via adenosine A2A receptors,” which will be published online December 19 in The Journal of Experimental Medicine, suggests that replacing the missing gut bacteria, or restoring a key metabolite called inosine, could help treat children with a rare and often fatal autoimmune disease called IPEX syndrome.